4//SEC Filing
Fox Christine Ann 4
Accession 0000950170-24-078467
CIK 0001719714other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:15 PM ET
Size
7.8 KB
Accession
0000950170-24-078467
Insider Transaction Report
Form 4
Fox Christine Ann
Chief Financial Officer
Transactions
- Sale
American Depositary Shares representing Ordinary Shares
2024-06-25$3.69/sh−12,990$47,984→ 87,010 total - Sale
American Depositary Shares representing Ordinary Shares
2024-06-26$3.39/sh−29,439$99,892→ 57,571 total
Footnotes (4)
- [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
- [F2]Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on June 21, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $3.60 to $3.805, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc ("Mereo"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $3.28 to $3.51, inclusive.
Documents
Issuer
Mereo BioPharma Group plc
CIK 0001719714
Entity typeother
Related Parties
1- filerCIK 0002005755
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:15 PM ET
- Size
- 7.8 KB